This post is sponsored by Celgene.
This chronic condition is characterized by pain, stiffness, and swelling and tenderness of the joints, but it can also cause tenderness, pain, and swelling of tendons. While the exact cause of psoriatic arthritis is unclear, many people with the condition have a family history; physical trauma or infection may trigger it, as well.4
Symptoms of psoriatic arthritis usually appear between the ages of 30 and 50 but may be confused with symptoms of other conditions.5,6 Although psoriatic arthritis affects over 1 million people in the United States, it is believed that many more people live with the condition, undiagnosed.7,8
Celgene, the maker of Otezla® (apremilast), has introduced the “pSAY YES!” program, a patient-focused initiative to help those with psoriatic arthritis address the day-to-day impact of this chronic condition. The program will help patients “pSAY YES” to a different approach to disease management, including treatment.
Last year, the US Food and Drug Administration (FDA) approved Otezla, the first and only oral therapy approved for the treatment of adults with active psoriatic arthritis.